Trial Profile
Single-center, randomized, open-label, 2-way crossover bioavailability study, evaluating the effect of food on Megace ES (megestrol acetate 625 mg/5 mL oral suspension) [megestrol] following a 625 mg dose in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Apr 2016
Price :
$35
*
At a glance
- Drugs Megestrol (Primary)
- Indications Anorexia; Cachexia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Par Pharmaceutical Inc
- 08 Apr 2008 New trial record.